Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids. | EJNMMI Res | 2024 | 38453813 | PubTator, text mining | PubMed |
| Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer. | Heliyon | 2024 | 38298669 | PubTator, text mining | PubMed |
| Inflammatory response in gastrointestinal cancers: Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications. | World J Clin Oncol | 2024 | 38292664 | PubTator, text mining | PubMed |
| Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment. | Int J Gen Med | 2024 | 38268861 | PubTator, text mining | PubMed |
| The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications. | Int J Mol Sci | 2024 | 38256141 | PubTator, text mining | PubMed |
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
| Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature. | Biologics | 2024 | 38250216 | PubTator, text mining | PubMed |
| Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages. | Cells | 2024 | 38247813 | PubTator, text mining | PubMed |
| Celecoxib and cisplatin dual-loaded microspheres synergistically enhance transarterial chemoembolization effect of hepatocellular carcinoma. | Mater Today Bio | 2024 | 38234462 | PubTator, text mining | PubMed |
| Effective prognostic risk model with cuproptosis-related genes in laryngeal cancer. | Braz J Otorhinolaryngol | 2024 | 38228050 | PubTator, text mining | PubMed |
| Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies. | Cell Death Discov | 2024 | 38218941 | PubTator, text mining | PubMed |
| Immunomodulation of cuproptosis and ferroptosis in liver cancer. | Cancer Cell Int | 2024 | 38200525 | PubTator, text mining | PubMed |
| Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer. | Clin Med Insights Oncol | 2024 | 38187458 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of cuproptosis-related genes in the prognosis and immune infiltration of adrenocortical Carcinoma. | Heliyon | 2024 | 38187219 | PubTator, text mining | PubMed |
| Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway. | Int J Mol Med | 2024 | 38186308 | PubTator, text mining | PubMed |
| p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization. | Int J Biol Sci | 2024 | 38169635 | PubTator, text mining | PubMed |
| The Cross-Communication of Cuproptosis and Regulated Cell Death in Human Pathophysiology. | Int J Biol Sci | 2024 | 38164173 | PubTator, text mining | PubMed |
| Cuproptosis gene-related, neural network-based prognosis prediction and drug-target prediction for KIRC. | Cancer Med | 2024 | 38131663 | PubTator, text mining | PubMed |
| Dry and wet experiments reveal diagnostic clustering and immune landscapes of cuproptosis patterns in patients with ankylosing spondylitis. | Int Immunopharmacol | 2024 | 38091828 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs ovarian cancer: Multi-omics analysis of molecular mechanisms and potential therapeutic targets. | Environ Toxicol | 2024 | 38019212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=10